Federation des caisses Desjardins du Quebec’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.4M Buy
189,702
+51,309
+37% +$7.19M 0.1% 162
2025
Q4
$17M Buy
138,393
+19,911
+17% +$2.42M 0.06% 211
2025
Q3
$13.2M Buy
118,482
+18,450
+18% +$2.1M 0.05% 230
2025
Q2
$11.1M Buy
100,032
+4,897
+5% +$521K 0.05% 237
2025
Q1
$10.7M Buy
95,135
+6,563
+7% +$677K 0.05% 224
2024
Q4
$8.18M Buy
88,572
+27,695
+45% +$2.49M 0.04% 252
2024
Q3
$5.1M Sell
60,877
-11,577
-16% -$883K 0.03% 335
2024
Q2
$4.97M Sell
72,454
-7,464
-9% -$498K 0.03% 326
2024
Q1
$6.09M Buy
79,918
+39,999
+100% +$3.08M 0.04% 270
2023
Q4
$3.23M Buy
39,919
+11,531
+41% +$897K 0.03% 336
2023
Q3
$2.13M Sell
28,388
-2,809
-9% -$216K 0.02% 402
2023
Q2
$2.4M Buy
31,197
+9,170
+42% +$731K 0.02% 396
2023
Q1
$1.83M Sell
22,027
-32,945
-60% -$2.73M 0.02% 425
2022
Q4
$4.72M Sell
54,972
-15,036
-21% -$1.19M 0.06% 237
2022
Q3
$4.32M Buy
70,008
+17,534
+33% +$1.11M 0.05% 255
2022
Q2
$3.24M Buy
52,474
+4,906
+10% +$304K 0.04% 308
2022
Q1
$2.83M Buy
47,568
+4,643
+11% +$297K 0.03% 361
2021
Q4
$3.12M Buy
42,925
+27,842
+185% +$1.92M 0.03% 349
2021
Q3
$1.05M Sell
15,083
-1,241
-8% -$87.2K 0.01% 675
2021
Q2
$1.12M Sell
16,324
-97,177
-86% -$6.49M 0.01% 674
2021
Q1
$7.34M Sell
113,501
-88,476
-44% -$5.71M 0.08% 201
2020
Q4
$11.8M Buy
201,977
+22,159
+12% +$1.34M 0.14% 140
2020
Q3
$11.4M Buy
179,818
+168,698
+1,517% +$11.7M 0.16% 126
2020
Q2
$856K Sell
11,120
-403
-3% -$30.9K 0.01% 559
2020
Q1
$861K Sell
11,523
-27,625
-71% -$1.91M 0.02% 545
2019
Q4
$2.54M Sell
39,148
-3,707
-9% -$241K 0.04% 369
2019
Q3
$2.72M Sell
42,855
-896
-2% -$58.6K 0.04% 340
2019
Q2
$2.96M Sell
43,751
-7,237
-14% -$476K 0.04% 315
2019
Q1
$3.31M Buy
50,988
+280
+0.6% +$18.6K 0.05% 288
2018
Q4
$3.17M Sell
50,708
-22,329
-31% -$1.56M 0.05% 284
2018
Q3
$5.64M Sell
73,037
-52,745
-42% -$3.98M 0.08% 208
2018
Q2
$8.92M Buy
125,782
+74,380
+145% +$5.25M 0.13% 134
2018
Q1
$3.88M Sell
51,402
-16,164
-24% -$1.28M 0.06% 268
2017
Q4
$4.84M Sell
67,566
-548
-0.8% -$41.6K 0.07% 222
2017
Q3
$5.52M Sell
68,114
-8,315
-11% -$636K 0.09% 204
2017
Q2
$5.41M Sell
76,429
-15,587
-17% -$1.04M 0.09% 207
2017
Q1
$6.25M Buy
+92,016
New +$6.47M 0.12% 157

Other funds holding GILD

Federation des caisses Desjardins du Quebec's GILD Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec increased its Gilead Sciences (GILD) stake by 37% in Q1 2026, buying an estimated $7.19M and bringing the position to 189,702 shares worth $26.4M. The position accounts for 0.1% of the portfolio, ranked #162.

Federation des caisses Desjardins du Quebec first reported a position in GILD in Q1 2017 and has held it in 37 quarters since. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 189,702 shares of Gilead Sciences worth $26.4M as of Q1 2026.
  • Federation des caisses Desjardins du Quebec bought 51,309 Gilead Sciences shares in Q1 2026, an estimated $7.19M.
  • Gilead Sciences made up 0.1% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #162 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Gilead Sciences in Q1 2017 and has held it in 37 quarters since.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.